UNIVERSITY OF FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1853-01-01

Employees: 10K

Market Cap: -

Website: http://www.ufl.edu

Clinical Trials

The Absorption of Bioactive Berberine in Human

Not Applicable

Completed

Conditions: Healthy

Interventions: Dietary Supplement: Berberine
Dietary Supplement: TPGS emulsified berberine
Dietary Supplement: Quillaja extract emulsified berberine

First Posted Date: 2018-02-19

Last Posted Date: 2021-01-27

Lead Sponsor: University of Florida

Target Recruit Count: 32

Registration Number: NCT03438292

Locations: 🇺🇸
Food Science and human nutrition department at University of Florida, Gainesville, Florida, United States

Parent/Caregiver Conference Attendance Feasibility

Completed

Conditions: Health Knowledge, Attitudes, Practice

Interventions: Behavioral: Applicant Survey

First Posted Date: 2018-02-14

Last Posted Date: 2021-02-26

Lead Sponsor: University of Florida

Target Recruit Count: 84

Registration Number: NCT03432585

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Not Applicable

Not yet recruiting

Conditions: Human Papillomavirus (HPV) Vaccines

Interventions: Behavioral: Protect Me 4 Application + External Quality Improvement Support
Behavioral: Protect Me 4 Application Alone

First Posted Date: 2018-02-12

Last Posted Date: 2024-07-16

Lead Sponsor: University of Florida

Target Recruit Count: 1296

Registration Number: NCT03429413

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

Health-Smart for Weight Loss at UF Jax Clinics

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Health Smart for Weight Loss

First Posted Date: 2018-02-01

Last Posted Date: 2024-10-17

Lead Sponsor: University of Florida

Target Recruit Count: 683

Registration Number: NCT03418701

Locations: 🇺🇸
UF Health Jacksonville Primary Care network, Jacksonville, Florida, United States

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Phase 4

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Drug: High dose potent statin
Drug: ACE-I (lisinopril) or ARB (losartan)
Drug: Aspirin
Behavioral: Lifestyle Counseling
Behavioral: Quality of Life Questionnaires

First Posted Date: 2018-01-31

Last Posted Date: 2025-02-06

Lead Sponsor: University of Florida

Target Recruit Count: 2476

Registration Number: NCT03417388

Locations: 🇺🇸
Lutheran Health Physicians, Fort Wayne, Indiana, United States
🇺🇸
Silver State Cardiology, Henderson, Nevada, United States
🇺🇸
The Valley Hospital, Ridgewood, New Jersey, United States

and more 78 locations

RHAPSody: Diagnostic Utility of RUSH Following ROSC

Terminated

Conditions: Cardiac Arrest

Interventions: Device: RUSH Exam

First Posted Date: 2018-01-24

Last Posted Date: 2022-12-27

Lead Sponsor: University of Florida

Target Recruit Count: 5

Registration Number: NCT03409289

Locations: 🇺🇸
University of Florida Health (UFHealth), Gainesville, Florida, United States

LIPIDS-P Trial Phase I/II

Phase 1

Recruiting

Conditions: Sepsis, Severe
Septic Shock

Interventions: Drug: Smoflipid

First Posted Date: 2018-01-23

Last Posted Date: 2022-01-12

Lead Sponsor: University of Florida

Target Recruit Count: 68

Registration Number: NCT03405870

Locations: 🇺🇸
UF Health Jacksonville North campus, Jacksonville, Florida, United States
🇺🇸
Department of Emergency Medicine, UF Health Jax ICU/MICU, Jacksonville, Florida, United States
🇺🇸
UF Health Jacksonville, Jacksonville, Florida, United States

A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care

Not Applicable

Completed

Conditions: Colo-rectal Cancer

Interventions: Other: virtual technology - tailored minimally
Other: virtual technology - highly tailored

First Posted Date: 2018-01-23

Last Posted Date: 2025-05-06

Lead Sponsor: University of Florida

Target Recruit Count: 960

Registration Number: NCT03407417

Locations: 🇺🇸
University of Florida, Jacksonville, Florida, United States

Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

Phase 2

Active, not recruiting

Conditions: Glioblastoma
Glioblastoma, WHO Grade IV

Interventions: Drug: Temozolomide (TMZ)
Device: Optune System
Drug: Pembrolizumab

First Posted Date: 2018-01-23

Last Posted Date: 2024-10-23

Lead Sponsor: University of Florida

Target Recruit Count: 40

Registration Number: NCT03405792

Locations: 🇺🇸
University of Florida Health, Gainesville, Florida, United States

Peripheral Nerve Blocks for Above-the-knee Amputations

Phase 4

Recruiting

Conditions: Peripheral Vascular Diseases
Hypertension
Hyperglycaemia (Diabetic)
Coronary Artery Disease
Pulmonary Disease, Chronic Obstructive

Interventions: Procedure: Peripheral nerve block
Drug: Intravenous Sedatives
Procedure: Lateral femoral cutaneous nerve blocks
Procedure: Obturator nerve blocks

First Posted Date: 2018-01-19

Last Posted Date: 2024-08-26

Lead Sponsor: University of Florida

Target Recruit Count: 36

Registration Number: NCT03404180

Locations: 🇺🇸
University of Florida, Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy